Product Name

  • Name

    Tretinoin

  • EINECS 206-129-0
  • CAS No. 302-79-4
  • Article Data98
  • CAS DataBase
  • Density 1.011 g/cm3
  • Solubility insoluble in water
  • Melting Point 179-184 °C
  • Formula C20H28O2
  • Boiling Point 462.8 °C at 760 mmHg
  • Molecular Weight 300.441
  • Flash Point 350.6 °C
  • Transport Information
  • Appearance yellow-orange powder
  • Safety 53-26-36/37/39-45-36/37
  • Risk Codes 22-63-38-20/21/22
  • Molecular Structure Molecular Structure of 302-79-4 (Tretinoin)
  • Hazard Symbols ToxicT,HarmfulXn
  • Synonyms (2E,4E,6E,8E)-3,7-dimethyl-9-(2,6,6-trimethyl-1-cyclohexenyl)nona-2,4,6,8-tetraenoate;all-trans-beta-Retinoic acid;Vitamin A acid;Tretinoine (French) (EINECS);Retin A;trans-Retinoic acid;all-trans-Vitamin A1 acid;Acide retinoique (French) (DSL);2,4, 6,8-Nonatetranoic acid, 3,7-dimethyl-9-(2,6, 6-trimethyl-1-cyclohexen-1-yl)-, (2E, 4E, 6E, 8E)-;all-trans-Retinoate;AGN 100335;Vitamin A acid sodium salt;Vitamin A1 acid, all-trans-;ATRA;Retin-A;Vesnaroid;Tretin M;all-(E)-Retinoic acid;Retinoic acid, sodium salt;beta-Retinoic acid;Cordes Vas;Aberel;Tretinoin, all-trans-;Retionic acid;Dermairol;Eudyna;Aknefug;Retinoate;all-trans-Retinoic acid;Retacnyl;Tretinoin (all-trans retinoic acid );Tretinoin USP26;
  • PSA 37.30000
  • LogP 5.60260

Synthetic route

ethyl (all-E)-retinoate
3899-20-5

ethyl (all-E)-retinoate

all-trans-retinoic-acid
302-79-4

all-trans-retinoic-acid

Conditions
ConditionsYield
With sodium hydroxide In methanol at 50℃; for 0.5h;98%
With potassium hydroxide In ethanol83%
With potassium hydroxide In ethanol at 50℃;83%
With potassium hydroxide In ethanol for 0.166667h; Heating;71%
RETINOL
68-26-8

RETINOL

all-trans-retinoic-acid
302-79-4

all-trans-retinoic-acid

Conditions
ConditionsYield
With tris(triphenylphosphine)ruthenium(II) chloride; oxygen; bis-(3-methyl-1-imidazolyl)ethylene tetrafluoroborate In hexane at 50℃; under 760.051 Torr; for 3h; Reagent/catalyst; Darkness;90.2%
Multi-step reaction with 2 steps
1: MnO2 / CH2Cl2 / 2 h / Ambient temperature
2: 80 percent / AgO, NaCN / methanol / 18 h / Ambient temperature
View Scheme
Multi-step reaction with 2 steps
1: 90 percent / MnO2 / CH2Cl2 / Ambient temperature
2: AgO / CNNa / methanol
View Scheme
(6R,7R)-3-[(2E,4E,6E,8E)-3,7-Dimethyl-9-(2,6,6-trimethyl-cyclohex-1-enyl)-nona-2,4,6,8-tetraenoyloxymethyl]-5,8-dioxo-7-(2-phenoxy-acetylamino)-5λ4-thia-1-aza-bicyclo[4.2.0]oct-2-ene-2-carboxylic acid
370578-75-9

(6R,7R)-3-[(2E,4E,6E,8E)-3,7-Dimethyl-9-(2,6,6-trimethyl-cyclohex-1-enyl)-nona-2,4,6,8-tetraenoyloxymethyl]-5,8-dioxo-7-(2-phenoxy-acetylamino)-5λ4-thia-1-aza-bicyclo[4.2.0]oct-2-ene-2-carboxylic acid

A

all-trans-retinoic-acid
302-79-4

all-trans-retinoic-acid

B

(R)-2-[(R)-Carboxy-(2-phenoxy-acetylamino)-methyl]-5-methylene-1-oxo-1,2,5,6-tetrahydro-1λ4-[1,3]thiazine-4-carboxylic acid

(R)-2-[(R)-Carboxy-(2-phenoxy-acetylamino)-methyl]-5-methylene-1-oxo-1,2,5,6-tetrahydro-1λ4-[1,3]thiazine-4-carboxylic acid

Conditions
ConditionsYield
With β-lactamase from Staphylococcus aureus 95; deuterated phosphate buffer In dimethylsulfoxide-d6 at 25℃; pH=7.2;A n/a
B 86%
trans-β-formyl crotonic acid
54168-84-2

trans-β-formyl crotonic acid

[3-methyl-5-(2,6,6-trimethylcyclohexene-1-yl)-2E,4E-pentadiene]-triphenyl phosphonic chloride

[3-methyl-5-(2,6,6-trimethylcyclohexene-1-yl)-2E,4E-pentadiene]-triphenyl phosphonic chloride

all-trans-retinoic-acid
302-79-4

all-trans-retinoic-acid

Conditions
ConditionsYield
Stage #1: trans-β-formyl crotonic acid; [3-methyl-5-(2,6,6-trimethylcyclohexene-1-yl)-2E,4E-pentadiene]-triphenyl phosphonic chloride With potassium hydroxide In isopropyl alcohol at -5 - 0℃; for 2h; Wittig Olefination; Inert atmosphere;
Stage #2: With hydrogenchloride; palladium diacetate In isopropyl alcohol at 50℃; pH=7 - 8; pH-value; Reagent/catalyst; Temperature;
85.3%
trans-β-formyl crotonic acid
54168-84-2

trans-β-formyl crotonic acid

[(2E,4E)-3-methyl-5-(2,6,6-trimethylcyclohex-1-en-1-yl)penta-2,4-dienyl]triphenylphosphonium chloride
53282-28-3

[(2E,4E)-3-methyl-5-(2,6,6-trimethylcyclohex-1-en-1-yl)penta-2,4-dienyl]triphenylphosphonium chloride

all-trans-retinoic-acid
302-79-4

all-trans-retinoic-acid

Conditions
ConditionsYield
Stage #1: trans-β-formyl crotonic acid; [(2E,4E)-3-methyl-5-(2,6,6-trimethylcyclohex-1-en-1-yl)penta-2,4-dienyl]triphenylphosphonium chloride With potassium hydroxide In isopropyl alcohol at -5 - 0℃; for 2h; Wittig Olefination; Inert atmosphere;
Stage #2: With hydrogenchloride; palladium diacetate In isopropyl alcohol at 50℃; pH=7-8; Reagent/catalyst; Temperature; pH-value; Inert atmosphere;
85.3%
all-trans-Retinal
116-31-4

all-trans-Retinal

all-trans-retinoic-acid
302-79-4

all-trans-retinoic-acid

Conditions
ConditionsYield
With silver(II) oxide; sodium cyanide In methanol for 18h; Ambient temperature;80%
With sodium cyanide; silver(l) oxide80%
With silver(II) oxide; sodium cyanide In methanol Yield given;
Conditions
ConditionsYield
With potassium hydroxide In ethanol for 0.5h; Heating; Yield given;A n/a
B 77%
With potassium hydroxide In ethanol for 0.5h; Heating; Yields of byproduct given;A n/a
B 77%
(2E,4E)-5-iodo-3-methylpenta-2,4-dienoic acid
220212-06-6

(2E,4E)-5-iodo-3-methylpenta-2,4-dienoic acid

tributyl[(1E,3E)-2-methyl-4-(2,6,6-trimethylcyclohex-1-enyl)buta-1,3-dienyl]stannane

tributyl[(1E,3E)-2-methyl-4-(2,6,6-trimethylcyclohex-1-enyl)buta-1,3-dienyl]stannane

all-trans-retinoic-acid
302-79-4

all-trans-retinoic-acid

Conditions
ConditionsYield
[PdCl2(NCMe)2] In N,N-dimethyl-formamide at 25℃; for 3h; Stille cross-coupling reaction;73%
acide-2-carboxy-3,7-dimethyl-9-(2,6,6-trimethyl-cyclohex-1-enyl)-nona-2E,4E,6E,8E-tetraenoique
20013-34-7

acide-2-carboxy-3,7-dimethyl-9-(2,6,6-trimethyl-cyclohex-1-enyl)-nona-2E,4E,6E,8E-tetraenoique

all-trans-retinoic-acid
302-79-4

all-trans-retinoic-acid

Conditions
ConditionsYield
With pyridine In dichloromethane67%
5-(2,6,6-trimethyl-cyclohex-1-enyl)-3-methyl-1-phenyl-sulphonyl-penta-2,4-diene
38987-91-6

5-(2,6,6-trimethyl-cyclohex-1-enyl)-3-methyl-1-phenyl-sulphonyl-penta-2,4-diene

(E)-4-bromo-3-methyl-2-butenoic acid
19041-16-8

(E)-4-bromo-3-methyl-2-butenoic acid

all-trans-retinoic-acid
302-79-4

all-trans-retinoic-acid

Conditions
ConditionsYield
Stage #1: 5-(2,6,6-trimethyl-cyclohex-1-enyl)-3-methyl-1-phenyl-sulphonyl-penta-2,4-diene With potassium tert-butylate In tetrahydrofuran at -20℃; for 0.5h;
Stage #2: (E)-4-bromo-3-methyl-2-butenoic acid In tetrahydrofuran at -20 - 60℃; for 4h; Julia olefination;
65%
β-ionone
105593-28-0

β-ionone

methylmagnesium bromide
75-16-1

methylmagnesium bromide

dimethyl 2-[(2E)-3-(dimethylamino)-1-methyl-2-propenylidene]malonate
419550-09-7

dimethyl 2-[(2E)-3-(dimethylamino)-1-methyl-2-propenylidene]malonate

A

13-cis-retinoic acid
4759-48-2

13-cis-retinoic acid

B

all-trans-retinoic-acid
302-79-4

all-trans-retinoic-acid

Conditions
ConditionsYield
Multistep reaction.;A 12%
B 61%
acide-2-carboxy-3,7-dimethyl-9-(2,6,6-trimethyl-cyclohex-1-enyl)-nona-2E,4E,6E,8E-tetraenoique
20013-34-7

acide-2-carboxy-3,7-dimethyl-9-(2,6,6-trimethyl-cyclohex-1-enyl)-nona-2E,4E,6E,8E-tetraenoique

A

13-cis-retinoic acid
4759-48-2

13-cis-retinoic acid

B

all-trans-retinoic-acid
302-79-4

all-trans-retinoic-acid

Conditions
ConditionsYield
With pyridine In dichloromethane at 20℃; for 20h;A n/a
B 60%
With barium dihydroxide In benzene for 0.5h;
aqueous potassium hydroxide

aqueous potassium hydroxide

aqueous sodium chlorite

aqueous sodium chlorite

2-methyl-but-2-ene
513-35-9

2-methyl-but-2-ene

all-trans-Retinal
116-31-4

all-trans-Retinal

all-trans-retinoic-acid
302-79-4

all-trans-retinoic-acid

Conditions
ConditionsYield
With phosphoric acid In 1,4-dioxane; ethanol; hexane55.9%
[(2Z,4E)-3-methyl-5-(2,6,6-trimethylcyclohex-1-en-1-yl)penta-2,4-dienyl]triphenylphosphonium chloride

[(2Z,4E)-3-methyl-5-(2,6,6-trimethylcyclohex-1-en-1-yl)penta-2,4-dienyl]triphenylphosphonium chloride

all-trans-retinoic-acid
302-79-4

all-trans-retinoic-acid

Conditions
ConditionsYield
Stage #1: [(2Z,4E)-3-methyl-5-(2,6,6-trimethylcyclohex-1-en-1-yl)penta-2,4-dienyl]triphenylphosphonium chloride With sodium methylate In methanol at -7.5℃; for 1h; Wittig Reaction;
Stage #2: With methanol; sodium hydroxide; ethanol; water at 20℃; Heating / reflux;
Stage #3: With water; acetic acid In dichloromethane
46%
Conditions
ConditionsYield
With potassium hydroxide In ethanol; water for 2h; Heating;A 38%
B n/a
retinoyl fluoride
83802-77-1

retinoyl fluoride

all-trans-retinoic-acid
302-79-4

all-trans-retinoic-acid

Conditions
ConditionsYield
With water In isopropyl alcohol for 23h;38%
(2E,4E,6E,8E)-3,7-dimethyl-9-{6,6-dimethyl-2-(4,4,5,5-tetramethyl-1,3,2-dioxaborolanyl)-1-cyclohexenyl}-2,4,6,8-nonatetraenoicacid ethyl ester
1620084-74-3

(2E,4E,6E,8E)-3,7-dimethyl-9-{6,6-dimethyl-2-(4,4,5,5-tetramethyl-1,3,2-dioxaborolanyl)-1-cyclohexenyl}-2,4,6,8-nonatetraenoicacid ethyl ester

methyl iodide
74-88-4

methyl iodide

A

13-cis-retinoic acid
4759-48-2

13-cis-retinoic acid

C

all-trans-retinoic-acid
302-79-4

all-trans-retinoic-acid

Conditions
ConditionsYield
Stage #1: (2E,4E,6E,8E)-3,7-dimethyl-9-{6,6-dimethyl-2-(4,4,5,5-tetramethyl-1,3,2-dioxaborolanyl)-1-cyclohexenyl}-2,4,6,8-nonatetraenoicacid ethyl ester; methyl iodide With tris-(dibenzylideneacetone)dipalladium(0); potassium carbonate; tris-(o-tolyl)phosphine In water; N,N-dimethyl-formamide at 60℃; for 0.0833333h; Inert atmosphere; Schlenk technique;
Stage #2: With potassium hydroxide In methanol; water; N,N-dimethyl-formamide at 100℃; for 0.0333333h; Inert atmosphere; Schlenk technique;
Stage #3: With formic acid In methanol; water; N,N-dimethyl-formamide Inert atmosphere; Schlenk technique;
A 10%
B 0.5%
C 32%
trans-β-formyl crotonic acid
54168-84-2

trans-β-formyl crotonic acid

(1E)-1-(2,6,6-trimethylcyclohex-1-enyl)-3-methyl-1,4-pentadien-3-ol
59057-30-6

(1E)-1-(2,6,6-trimethylcyclohex-1-enyl)-3-methyl-1,4-pentadien-3-ol

all-trans-retinoic-acid
302-79-4

all-trans-retinoic-acid

Conditions
ConditionsYield
With triphenylphosphine
ethyl 3-methylbut-2-enoate
638-10-8

ethyl 3-methylbut-2-enoate

(2E,4E)-3-methyl-5-(2,6,6-trimethyl-1-cyclohexen-1-yl)-2,4-pentadienal
3917-41-7

(2E,4E)-3-methyl-5-(2,6,6-trimethyl-1-cyclohexen-1-yl)-2,4-pentadienal

all-trans-retinoic-acid
302-79-4

all-trans-retinoic-acid

Conditions
ConditionsYield
With potassium amide
(+/-)-7-hydroxy-3.7-dimethyl-1t-(2.2.6-trimethyl-cyclohexen-(6)-yl)-nonatrien-(1.3t.5t)-oic acid-(9)-ethyl ester
115207-29-9

(+/-)-7-hydroxy-3.7-dimethyl-1t-(2.2.6-trimethyl-cyclohexen-(6)-yl)-nonatrien-(1.3t.5t)-oic acid-(9)-ethyl ester

all-trans-retinoic-acid
302-79-4

all-trans-retinoic-acid

Conditions
ConditionsYield
With iodine; Petroleum ether Behandeln des erhaltenen all-trans-Retinsaeure-aethylesters mit wss.-aethanol. Kalilauge unter Stickstoff bei Lichtausschluss;
(+/-)-7-hydroxy-3.7-dimethyl-1t-(2.2.6-trimethyl-cyclohexen-(6)-yl)-nonatrien-(1.3t.5t)-oic acid-(9)-methyl ester

(+/-)-7-hydroxy-3.7-dimethyl-1t-(2.2.6-trimethyl-cyclohexen-(6)-yl)-nonatrien-(1.3t.5t)-oic acid-(9)-methyl ester

all-trans-retinoic-acid
302-79-4

all-trans-retinoic-acid

Conditions
ConditionsYield
With oxalic acid unter vermindertem Druck und Behandeln mit methanol. oder aethanol. Kalilauge;
With toluene-4-sulfonic acid; benzene Behandeln mit methanol. oder aethanol. Kalilauge;
With phenyl isocyanate at 110℃; Behandeln mit methanol. oder aethanol. Kalilauge;
(2E,4E,6E,8E)-3,7-Dimethyl-9-(2,6,6-trimethyl-cyclohex-1-enyl)-nona-2,4,6,8-tetraenoic acid
302-79-4, 3555-80-4, 4759-48-2, 5300-03-8, 5352-74-9, 68070-34-8, 68070-35-9, 97950-17-9, 98462-64-7, 124510-04-9

(2E,4E,6E,8E)-3,7-Dimethyl-9-(2,6,6-trimethyl-cyclohex-1-enyl)-nona-2,4,6,8-tetraenoic acid

all-trans-retinoic-acid
302-79-4

all-trans-retinoic-acid

Conditions
ConditionsYield
With iodine
methyl 5-benzenesulphonyl-3.7-dimethyl-9-(2'.6'.6'.trimethyl-cyclohexen-1'-yl)-2.6.8-nonatrienoate
41551-56-8, 78088-24-1, 78088-25-2, 78088-26-3

methyl 5-benzenesulphonyl-3.7-dimethyl-9-(2'.6'.6'.trimethyl-cyclohexen-1'-yl)-2.6.8-nonatrienoate

A

13-cis-retinoic acid
4759-48-2

13-cis-retinoic acid

B

all-trans-retinoic-acid
302-79-4

all-trans-retinoic-acid

Conditions
ConditionsYield
With potassium hydroxide In methanol for 2.5h; Heating; Yield given. Yields of byproduct given;
8-<2-(methylthio)-1,3-dithian-2-yl>-3,7-dimethyl-1-(2,6,6-trimethylcyclohex-1-enyl)octa-1E,3E,5E,7E-tetraene
146558-55-6

8-<2-(methylthio)-1,3-dithian-2-yl>-3,7-dimethyl-1-(2,6,6-trimethylcyclohex-1-enyl)octa-1E,3E,5E,7E-tetraene

A

13-cis-retinoic acid
4759-48-2

13-cis-retinoic acid

B

all-trans-retinoic-acid
302-79-4

all-trans-retinoic-acid

Conditions
ConditionsYield
Yield given. Multistep reaction. Yields of byproduct given;
(2E,4E,8E/2Z,4E,8E)-7-hydroxy-7-methyl-9-(2,6,6-trimethyl-1-cyclohexenyl)-nona-2,4,8-trienoic acid
131189-98-5, 131235-62-6

(2E,4E,8E/2Z,4E,8E)-7-hydroxy-7-methyl-9-(2,6,6-trimethyl-1-cyclohexenyl)-nona-2,4,8-trienoic acid

all-trans-retinoic-acid
302-79-4

all-trans-retinoic-acid

Conditions
ConditionsYield
With iodine; toluene-4-sulfonic acid 1.) methylene dichloride, reflux; 2.) diethyl ether/benzene, rt, 7 h; Yield given;
Multi-step reaction with 2 steps
1: 95 percent / p-toluenesulfonic acid / CH2Cl2 / Heating
2: I2
View Scheme
(E)-2-(but-1-en-3-ynyl)-1,3,3-trimethylcyclohex-1-ene
73395-75-2

(E)-2-(but-1-en-3-ynyl)-1,3,3-trimethylcyclohex-1-ene

(2E,4E)-5-iodo-3-methylpenta-2,4-dienoic acid
220212-06-6

(2E,4E)-5-iodo-3-methylpenta-2,4-dienoic acid

methyl iodide
74-88-4

methyl iodide

all-trans-retinoic-acid
302-79-4

all-trans-retinoic-acid

Conditions
ConditionsYield
Yield given. Multistep reaction;
all-trans-Retinal
116-31-4

all-trans-Retinal

A

all-trans-retinoic-acid
302-79-4

all-trans-retinoic-acid

B

4-hydroxy-all-trans-retinal
18344-42-8

4-hydroxy-all-trans-retinal

Conditions
ConditionsYield
With rabbit liver microsomal P450 1A1 isozyme; NADPH; NADPH-cytochrome P450 reductase In phosphate buffer at 30℃; for 0.25h; pH=7.4; Enzyme kinetics; Further Variations:; Reaction partners; Oxidation; Enzymatic reaction;
trans-β-formyl crotonic acid
54168-84-2

trans-β-formyl crotonic acid

3-methyl-5t-<2,6,6-trimethyl-cyclohex-1-enyl>-penta-2t,4-dien-1-ol

3-methyl-5t-<2,6,6-trimethyl-cyclohex-1-enyl>-penta-2t,4-dien-1-ol

all-trans-retinoic-acid
302-79-4

all-trans-retinoic-acid

Conditions
ConditionsYield
With triphenylphosphine
4t-<2,6,6-trimethyl-cyclohex-1-enyl>-but-3-en-2-ol

4t-<2,6,6-trimethyl-cyclohex-1-enyl>-but-3-en-2-ol

3-methyl-6-oxo-hexa-2t,4t-dienoic acid

3-methyl-6-oxo-hexa-2t,4t-dienoic acid

all-trans-retinoic-acid
302-79-4

all-trans-retinoic-acid

Conditions
ConditionsYield
With triphenylphosphine
all-trans-retinoic-acid
302-79-4

all-trans-retinoic-acid

diazomethyl-trimethyl-silane
18107-18-1

diazomethyl-trimethyl-silane

all-trans-methyl retinoate
339-16-2

all-trans-methyl retinoate

Conditions
ConditionsYield
In methanol; hexane; benzene at 20℃; for 0.75h;100%
With methanol In benzene at 20℃; Methylation;
1-Hexadecanol
36653-82-4

1-Hexadecanol

all-trans-retinoic-acid
302-79-4

all-trans-retinoic-acid

retinyl palmitate
136013-95-1

retinyl palmitate

Conditions
ConditionsYield
With di-isopropyl azodicarboxylate; triphenylphosphine In tetrahydrofuran at 0℃; for 24h; optical yield given as %de;99%
all-trans-retinoic-acid
302-79-4

all-trans-retinoic-acid

C20H38O2

C20H38O2

Conditions
ConditionsYield
With palladium 10% on activated carbon; hydrogen In methanol at 20℃; under 760.051 Torr;99%
all-trans-retinoic-acid
302-79-4

all-trans-retinoic-acid

1,1'-carbonyldiimidazole
530-62-1

1,1'-carbonyldiimidazole

N-(all-trans-Retinoyl)-imidazole
61319-45-7

N-(all-trans-Retinoyl)-imidazole

Conditions
ConditionsYield
In acetonitrile for 1h; Heating;98.6%
In N,N-dimethyl-formamide Ambient temperature;80%
In benzene at 20℃; for 1h;60%
all-trans-retinoic-acid
302-79-4

all-trans-retinoic-acid

3-(tert-butyldisulfanyl)propane-1,2-diol
131111-38-1

3-(tert-butyldisulfanyl)propane-1,2-diol

(2E,4E,6E,8E)-3,7-Dimethyl-9-(2,6,6-trimethyl-cyclohex-1-enyl)-nona-2,4,6,8-tetraenoic acid 2-tert-butyldisulfanyl-1-[(2E,4E,6E,8E)-3,7-dimethyl-9-(2,6,6-trimethyl-cyclohex-1-enyl)-nona-2,4,6,8-tetraenoyloxymethyl]-ethyl ester
131111-41-6

(2E,4E,6E,8E)-3,7-Dimethyl-9-(2,6,6-trimethyl-cyclohex-1-enyl)-nona-2,4,6,8-tetraenoic acid 2-tert-butyldisulfanyl-1-[(2E,4E,6E,8E)-3,7-dimethyl-9-(2,6,6-trimethyl-cyclohex-1-enyl)-nona-2,4,6,8-tetraenoyloxymethyl]-ethyl ester

Conditions
ConditionsYield
With dmap; dicyclohexyl-carbodiimide In tetrahydrofuran for 12h; Ambient temperature;98%
Chloromethyl pivalate
18997-19-8

Chloromethyl pivalate

all-trans-retinoic-acid
302-79-4

all-trans-retinoic-acid

(2E,4E,6E,8E)-3,7-Dimethyl-9-(2,6,6-trimethyl-cyclohex-1-enyl)-nona-2,4,6,8-tetraenoic acid 2,2-dimethyl-propionyloxymethyl ester

(2E,4E,6E,8E)-3,7-Dimethyl-9-(2,6,6-trimethyl-cyclohex-1-enyl)-nona-2,4,6,8-tetraenoic acid 2,2-dimethyl-propionyloxymethyl ester

Conditions
ConditionsYield
With triethylamine In N,N-dimethyl-formamide at 70℃; for 3h; Alkylation;98%
all-trans-retinoic-acid
302-79-4

all-trans-retinoic-acid

vanillylamine hydrochloride
7149-10-2

vanillylamine hydrochloride

Retvanil

Retvanil

Conditions
ConditionsYield
With diethyl cyanophosphonate; triethylamine In tetrahydrofuran98%
all-trans-retinoic-acid
302-79-4

all-trans-retinoic-acid

(+)-octan-2-ol
6169-06-8

(+)-octan-2-ol

(+)-2-octanoyl retinoate
82838-02-6, 104013-58-3

(+)-2-octanoyl retinoate

Conditions
ConditionsYield
With dicyclohexyl-carbodiimide In diethyl ether 1.) 0 deg C, 30 min, 2.) 25 deg C, 1 h;96%
all-trans-retinoic-acid
302-79-4

all-trans-retinoic-acid

retinoyl chloride
53839-60-4

retinoyl chloride

4-amino-phenol
123-30-8

4-amino-phenol

(2E,4E,6E,8E)-[3,7-dimethyl-9-(2,6,6-trimethylcyclohex-1-enyl)-nona-2,4,6,8-tetraenoylamino]-4-hydroxyphenylamide

(2E,4E,6E,8E)-[3,7-dimethyl-9-(2,6,6-trimethylcyclohex-1-enyl)-nona-2,4,6,8-tetraenoylamino]-4-hydroxyphenylamide

Conditions
ConditionsYield
With thionyl chloride; triethylamine In N,N-dimethyl-formamide96%
ethanol
64-17-5

ethanol

all-trans-retinoic-acid
302-79-4

all-trans-retinoic-acid

ethyl (all-E)-retinoate
3899-20-5

ethyl (all-E)-retinoate

Conditions
ConditionsYield
With dicyclohexyl-carbodiimide In diethyl ether 1.) 0 deg C, 30 min, 2.) 25 deg C, 1 h;95%
(i) N,N'-carbonyl-di-imidazole, (ii) /BRN= 1718733/, NaOEt; Multistep reaction;
1,1'-Carbonyl-di-(1,2,4-triazole)
41864-22-6

1,1'-Carbonyl-di-(1,2,4-triazole)

all-trans-retinoic-acid
302-79-4

all-trans-retinoic-acid

1-(all-trans-Retinoyl)-1,2,4-triazol

1-(all-trans-Retinoyl)-1,2,4-triazol

Conditions
ConditionsYield
In acetonitrile for 1h; Heating;95%
In N,N-dimethyl-formamide 1.) RT; 15 min, 2.) 40 deg C, 4 h;87%
all-trans-retinoic-acid
302-79-4

all-trans-retinoic-acid

(+)-α-phenethyl alcohol
1517-69-7

(+)-α-phenethyl alcohol

(+)-α-phenethylretinoate
82838-01-5, 82863-17-0

(+)-α-phenethylretinoate

Conditions
ConditionsYield
With dicyclohexyl-carbodiimide In diethyl ether 1.) 0 deg C, 30 min, 2.) 25 deg C, 1 h;95%
all-trans-retinoic-acid
302-79-4

all-trans-retinoic-acid

(-)-α-phenethylretinoate
82838-01-5, 82863-17-0

(-)-α-phenethylretinoate

Conditions
ConditionsYield
With dicyclohexyl-carbodiimide In diethyl ether 1.) 0 deg C, 30 min, 2.) 25 deg C, 1 h;95%
all-trans-retinoic-acid
302-79-4

all-trans-retinoic-acid

2,3,4,6-tetra-O-acetyl-α-D-glucopyranosyl bromide
572-09-8

2,3,4,6-tetra-O-acetyl-α-D-glucopyranosyl bromide

all-trans-retinoic acid-2,3,4,6-tetra-O-acetyl-β-D-glucopyranosylester
73880-09-8

all-trans-retinoic acid-2,3,4,6-tetra-O-acetyl-β-D-glucopyranosylester

Conditions
ConditionsYield
With pyridine; silver(l) oxide for 1.5h;95%
chloromethyl isobutyrate
61644-18-6

chloromethyl isobutyrate

all-trans-retinoic-acid
302-79-4

all-trans-retinoic-acid

(2E,4E,6E,8E)-3,7-Dimethyl-9-(2,6,6-trimethyl-cyclohex-1-enyl)-nona-2,4,6,8-tetraenoic acid isobutyryloxymethyl ester

(2E,4E,6E,8E)-3,7-Dimethyl-9-(2,6,6-trimethyl-cyclohex-1-enyl)-nona-2,4,6,8-tetraenoic acid isobutyryloxymethyl ester

Conditions
ConditionsYield
With triethylamine In N,N-dimethyl-formamide at 70℃; for 3h; Alkylation;94%
1,3-diethyl 2-diazopropanedioate
5256-74-6

1,3-diethyl 2-diazopropanedioate

all-trans-retinoic-acid
302-79-4

all-trans-retinoic-acid

diethyl 2-(((2E,4E,6E,8E)-3,7-dimethyl-9-(2,6,6-trimethylcyclohex-1-en-1-yl)nona-2,4,6,8-tetraenoyl)oxy)malonate

diethyl 2-(((2E,4E,6E,8E)-3,7-dimethyl-9-(2,6,6-trimethylcyclohex-1-en-1-yl)nona-2,4,6,8-tetraenoyl)oxy)malonate

Conditions
ConditionsYield
With bis{rhodium[3,3'-(1,3-phenylene)bis(2,2-dimethylpropanoic acid)]} In dichloromethane at 20℃; for 0.166667h; Inert atmosphere;93%
all-trans-retinoic-acid
302-79-4

all-trans-retinoic-acid

5-[(fluoromethyl)(4-nitrophenyl)-λ4-sulfanylidene]-2,2-dimethyl-1,3-dioxane-4,6-dione

5-[(fluoromethyl)(4-nitrophenyl)-λ4-sulfanylidene]-2,2-dimethyl-1,3-dioxane-4,6-dione

(2E,4E,6E,8E)-fluoromethyl 3,7-dimethyl-9-(2,6,6-trimethylcyclohex-1-enyl)nona-2,4,6,8-tetraenoate

(2E,4E,6E,8E)-fluoromethyl 3,7-dimethyl-9-(2,6,6-trimethylcyclohex-1-enyl)nona-2,4,6,8-tetraenoate

Conditions
ConditionsYield
With tert-butylimino-tri(pyrrolidino)phosphorane In dichloromethane at 30℃; for 0.166667h; Schlenk technique;93%
all-trans-retinoic-acid
302-79-4

all-trans-retinoic-acid

(2-bromoethyl)(hexyl)(2-hydroxyethyl)phosphate
1609100-50-6

(2-bromoethyl)(hexyl)(2-hydroxyethyl)phosphate

2-((2-bromoethoxy)(hexyloxy)phosphoryl)ethoxyretinoate
1609100-56-2

2-((2-bromoethoxy)(hexyloxy)phosphoryl)ethoxyretinoate

Conditions
ConditionsYield
With dmap; N-ethyl-N,N-diisopropylamine; chlorotri(pyrrolidin-1-yl)phosphonium hexafluorophosphate In dichloromethane for 24h; Inert atmosphere; Reflux;92%
With dmap; N-ethyl-N,N-diisopropylamine; chlorotri(pyrrolidin-1-yl)phosphonium hexafluorophosphate In dichloromethane for 24h; Reflux; Inert atmosphere;92%
all-trans-retinoic-acid
302-79-4

all-trans-retinoic-acid

propargyl bromide
106-96-7

propargyl bromide

(2E,4E,6E,8E)-prop-2-yn-1-yl 3,7-dimethyl-9-(2,6,6-trimethylcyclohex-1-en-1-yl)nona-2,4,6,8-tetraenoate
58508-30-8

(2E,4E,6E,8E)-prop-2-yn-1-yl 3,7-dimethyl-9-(2,6,6-trimethylcyclohex-1-en-1-yl)nona-2,4,6,8-tetraenoate

Conditions
ConditionsYield
With caesium carbonate In tetrahydrofuran at 20℃; for 1h;92%
With caesium carbonate In tetrahydrofuran at 20℃;89%
1-ferrocenylmethanol
1273-86-5

1-ferrocenylmethanol

all-trans-retinoic-acid
302-79-4

all-trans-retinoic-acid

ferrocenylmethylretinoate

ferrocenylmethylretinoate

Conditions
ConditionsYield
With di-isopropyl azodicarboxylate; triphenylphosphine In tetrahydrofuran at 0 - 20℃; for 2h; Inert atmosphere;92%
With di-isopropyl azodicarboxylate; triphenylphosphine In tetrahydrofuran at 0 - 20℃; for 2h; Inert atmosphere;
all-trans-retinoic-acid
302-79-4

all-trans-retinoic-acid

4-hydroxy-benzaldehyde
123-08-0

4-hydroxy-benzaldehyde

4-formylphenyl(2E,4E,6E,8E)-3,7-dimethyl-9-(2,6,6-trimethylcyclohex-1-enyl)nona-2,4,6,8-tetraenoate
80850-73-3

4-formylphenyl(2E,4E,6E,8E)-3,7-dimethyl-9-(2,6,6-trimethylcyclohex-1-enyl)nona-2,4,6,8-tetraenoate

Conditions
ConditionsYield
With dmap; dicyclohexyl-carbodiimide In N,N-dimethyl-formamide at 20℃; for 24h;91%
With dmap; dicyclohexyl-carbodiimide In N,N-dimethyl-formamide at 20℃; for 24h;91%
all-trans-retinoic-acid
302-79-4

all-trans-retinoic-acid

ethylenediamine
107-15-3

ethylenediamine

C22H34N2O
1333107-97-3

C22H34N2O

Conditions
ConditionsYield
Stage #1: all-trans-retinoic-acid With 1-hydroxy-pyrrolidine-2,5-dione; dicyclohexyl-carbodiimide In dimethyl sulfoxide at 20℃; for 20h;
Stage #2: ethylenediamine In dimethyl sulfoxide at 20℃; for 24h;
91%
Stage #1: all-trans-retinoic-acid With 1-hydroxy-pyrrolidine-2,5-dione; 1-ethyl-(3-(3-dimethylamino)propyl)-carbodiimide hydrochloride In dichloromethane Cooling with ice;
Stage #2: ethylenediamine In dichloromethane at 20℃;
63%
all-trans-retinoic-acid
302-79-4

all-trans-retinoic-acid

retinoyl fluoride
83802-77-1

retinoyl fluoride

Conditions
ConditionsYield
With (2-chloro-1,2,2-trifluoro-ethyl)-diethyl-amine In tetrahydrofuran for 0.25h; Heating;90%
With perfluoropropylene; diethylamine
With diethylamino-sulfur trifluoride In diethyl ether 1.) -70 deg C, 60 min, 2.) r.t., 2 h;9.1 g
all-trans-retinoic-acid
302-79-4

all-trans-retinoic-acid

methyl (2S)-2-amino-3-phenylpropanoate
2577-90-4

methyl (2S)-2-amino-3-phenylpropanoate

N-(all-trans-retinoyl)-L-phenylalanine methyl ester
110683-03-9

N-(all-trans-retinoyl)-L-phenylalanine methyl ester

Conditions
ConditionsYield
With dmap; dicyclohexyl-carbodiimide In dichloromethane for 0.5h; Ambient temperature;90%
1-hydroxy-pyrrolidine-2,5-dione
6066-82-6

1-hydroxy-pyrrolidine-2,5-dione

EDAC [ethyl-3-(3-dimethylamino)propyl carbodiimide]

EDAC [ethyl-3-(3-dimethylamino)propyl carbodiimide]

all-trans-retinoic-acid
302-79-4

all-trans-retinoic-acid

Retinoic Acid N-Hydroxysuccinimide Ester

Retinoic Acid N-Hydroxysuccinimide Ester

Conditions
ConditionsYield
With sodium chloride; argon In ethyl acetate; N,N-dimethyl-formamide90%
With sodium chloride In ethyl acetate; N,N-dimethyl-formamide90%
1-hydroxy-pyrrolidine-2,5-dione
6066-82-6

1-hydroxy-pyrrolidine-2,5-dione

all-trans-retinoic-acid
302-79-4

all-trans-retinoic-acid

N-(all-trans-Retinoyloxy)-succinimide
65646-64-2

N-(all-trans-Retinoyloxy)-succinimide

Conditions
ConditionsYield
With dicyclohexyl-carbodiimide In tetrahydrofuran at 0 - 20℃; Inert atmosphere; Darkness;90%
With dicyclohexyl-carbodiimide In tetrahydrofuran at 0 - 25℃; for 0.208333h;73%
With dicyclohexyl-carbodiimide In dimethyl sulfoxide at 20℃; for 72h;
With 1-ethyl-(3-(3-dimethylamino)propyl)-carbodiimide hydrochloride; dmap In dichloromethane at 20℃; for 3h;
With dicyclohexyl-carbodiimide In tetrahydrofuran at 0 - 20℃;
all-trans-retinoic-acid
302-79-4

all-trans-retinoic-acid

3-Hydroxypropionitrile
109-78-4

3-Hydroxypropionitrile

(2E,4E,6E,8E)-2-cyanoethyl 3,7-dimethyl-9-(2,6,6-trimethylcyclohex-1-enyl)nona-2,4,6,8-tetraenoate
1225383-34-5

(2E,4E,6E,8E)-2-cyanoethyl 3,7-dimethyl-9-(2,6,6-trimethylcyclohex-1-enyl)nona-2,4,6,8-tetraenoate

Conditions
ConditionsYield
With dmap; 1-ethyl-(3-(3-dimethylamino)propyl)-carbodiimide hydrochloride In dichloromethane at 20℃; for 18h;90%
all-trans-retinoic-acid
302-79-4

all-trans-retinoic-acid

Propargylamine
2450-71-7

Propargylamine

(2E,4E,6E,8E)-N-(propargyl)-3,7-dimethyl-9-(2,6,6-trimethylcyclohex-1-en-1-yl)nona-2,4,6,8-tetraenamide

(2E,4E,6E,8E)-N-(propargyl)-3,7-dimethyl-9-(2,6,6-trimethylcyclohex-1-en-1-yl)nona-2,4,6,8-tetraenamide

Conditions
ConditionsYield
With N-ethyl-N,N-diisopropylamine; N-[(dimethylamino)-3-oxo-1H-1,2,3-triazolo[4,5-b]pyridin-1-yl-methylene]-N-methylmethanaminium hexafluorophosphate In dichloromethane at 20℃; Inert atmosphere;90%

Tretinoin Consensus Reports

Reported in EPA TSCA Inventory. EPA Genetic Toxicology Program.

Tretinoin Specification

The Tretinoin, with the CAS registry number 302-79-4,is also known as 3,7-Dimethyl-9-(2,6,6-trimethyl-1-cyclohexen-1-yl)-2,4,6,8-nonatetraenoic acid; all-trans-Retinoic acid; Vitamin A acid. It belongs to the product categories of Intermediates & Fine Chemicals;Retinoids;Intracellular receptor;API.Its EINECS number is 206-129-0. This chemical's molecular formula is C20H28O2 and molecular weight is 300.44. What's more,Its systematic name is Tretinoin.It is a yellow-orange powder which has been used to treat acne and other skin problems, and can be used for the unusual type of acne, psoriasis ichthyosis and abnormal.

Physical properties about Tretinoin are:
(1)ACD/LogP:  6.83; (2)# of Rule of 5 Violations:  1; (3)ACD/LogD (pH 5.5):  5.99; (4)ACD/LogD (pH 7.4):  4.19; (5)ACD/BCF (pH 5.5):  13226.03; (6)ACD/BCF (pH 7.4):  210.25; (7)ACD/KOC (pH 5.5):  17912.95; (8)ACD/KOC (pH 7.4):  284.76; (9)#H bond acceptors:  2; (10)#H bond donors:  1; (11)#Freely Rotating Bonds:  5; (12)Index of Refraction:  1.556; (13)Molar Refractivity:  95.527 cm3; (14)Molar Volume:  297.151 cm3; (15)Surface Tension:  39.1399993896484 dyne/cm; (16)Density:  1.011 g/cm3; (17)Flash Point:  350.596 °C; (18)Enthalpy of Vaporization:  79.324 kJ/mol; (19)Boiling Point:  462.801 °C at 760 mmHg; (20)Vapour Pressure:  0 mmHg at 25°C.3. Structure Descriptors of Tretinoin

You can still convert the following datas into molecular structure:
(1)SMILES:O=C(O)\C=C(\C=C\C=C(\C=C\C1=C(\CCCC1(C)C)C)C)C;
(2)Std. InChI:InChI=1S/C20H28O2/c1-15(8-6-9-16(2)14-19(21)22)11-12-18-17(3)10-7-13-20(18,4)5/h6,8-9,11-12,14H,7,10,13H2,1-5H3,(H,21,22)/b9-6+,12-11+,15-8+,16-14+;
(3)Std. InChIKey:SHGAZHPCJJPHSC-YCNIQYBTSA-N.

Safety Information of Tretinoin:
The Tretinoin is harmful by inhalation, in contact with skin and if swallowed and rritating to skin. It is possible risk of harm to the unborn child. In case of accident or if you feel unwell, seek medical advice immediately (show the label whenever possible.) .When you use it wear suitable protective clothing, gloves and eye/face protection. In case of contact with eyes, rinse immediately with plenty of water and seek medical advice. This chemical is danger to the environment Avoid exposure - obtain special instructions before use.

Toxicity of Tretinoin is as follows:

Organism Test Type Route Reported Dose (Normalized Dose) Effect Source
mouse LD50 intraperitoneal 208mg/kg (208mg/kg)   Drugs in Japan Vol. -, Pg. 886, 1995.
mouse LD50 intravenous 92mg/kg (92mg/kg)   United States Patent Document. Vol. #3878202,
mouse LD50 oral 1100mg/kg (1100mg/kg)   American Journal of Clinical Nutrition. Vol. 52, Pg. 183, 1990.
mouse LD50 subcutaneous 253mg/kg (253mg/kg) BEHAVIORAL: SLEEP

LUNGS, THORAX, OR RESPIRATION: RESPIRATORY DEPRESSION
Kiso to Rinsho. Clinical Report. Vol. 7, Pg. 3194, 1973.
rat LD50 intraperitoneal 96mg/kg (96mg/kg) SPINAL CORD: OTHER DEGENERATIVE CHANGES

BEHAVIORAL: ATAXIA

BLOOD: NORMOCYTIC ANEMIA
Kiso to Rinsho. Clinical Report. Vol. 7, Pg. 3194, 1973.
rat LD50 intravenous 75mg/kg (75mg/kg)   Drugs in Japan Vol. -, Pg. 886, 1995.
rat LD50 oral 2gm/kg (2000mg/kg)   American Journal of Clinical Nutrition. Vol. 52, Pg. 183, 1990.
rat LD50 subcutaneous 53mg/kg (53mg/kg) BEHAVIORAL: "HALLUCINATIONS, DISTORTED PERCEPTIONS"

LUNGS, THORAX, OR RESPIRATION: RESPIRATORY DEPRESSION
Kiso to Rinsho. Clinical Report. Vol. 7, Pg. 3194, 1973.

Post buying leads

About|Contact|Cas|Product Name|Molecular|Country|Encyclopedia

Message|New Cas|MSDS|Service|Advertisement|CAS DataBase|Article Data|Manufacturers | Chemical Catalog

©2008 LookChem.com,License: ICP

NO.:Zhejiang16009103

complaints:service@lookchem.com Desktop View